PRECISE-DAPT Score for Bleeding on DAPT
Predicts out-of-hospital bleeding risk during dual antiplatelet therapy (DAPT) to guide DAPT duration decisions post-PCI.
Score interpretation
PRECISE-DAPT < 25: Low out-of-hospital bleeding risk. Extended DAPT (24 months) favoured if ischaemic risk justifies.
→ Extended DAPT (24 months post-PCI) is reasonable. Reassess at 12 months.
PRECISE-DAPT ≥ 25: High bleeding risk. Shorter DAPT (3–6 months) preferred.
→ Short-course DAPT (3–6 months). Then aspirin monotherapy. Balance against ischaemic risk.
Interpretation bands for the PRECISE-DAPT. Apply clinical judgement and local guidance.
References
- Costa F et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score. Lancet. 2017;389(10073):1025-1034.
Related
Curated clinical cross-links plus same-class fallbacks.
- DAPT Score · Coronary Artery Disease
- Mehran Score for Post-PCI Contrast Nephropathy · Coronary Artery Disease
- Canadian Cardiovascular Society (CCS) Angina Grading · Coronary Artery Disease
- Duke Treadmill Score · Coronary Artery Disease
- ARC-HBR Criteria for High Bleeding Risk in PCI · Coronary Artery Disease
- SYNTAX Score for Coronary Artery Disease · Coronary Artery Disease
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.